RxDoctor Payments Data

Kjell Hult, MD

Anesthesiology · Pasadena, CANPI 1215958251

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by BD at 55.9% of the total. 2025 is the largest year on record at $1,520, more than ten times the $69 reported in 2019. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,562in general payments, 2019–2025

Across 24 payments — averaging $106.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$1K
  • Acacia Pharma Inc$264
  • Stryker$246
  • Pacira Pharmaceuticals Incorporated$185
  • La Jolla Pharmaceutical Company$142
  • Haemonetics Corporation$141
  • plus $153 from 5 others
$51,878in research payments, 2019–2025

Across 1 payment — averaging $51,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Heron Therapeutics, Inc.$52K

What the payments were for

  • Consulting fees$24610%
  • Speaking & faculty fees$1,43256%
  • Food & beverage$88435%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,562 in reported general payments places this provider in the 90th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California →

Medicare billing

Part B allowed, 2024
$71,645
Medicare patients
256
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Pasadena

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →